ADMA Projected Dividend Yield
ADMA Biologics Inc ( NASDAQ : ADMA )ADMA BIOLOGICS, INC. is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Co.'s products include: BIVIGAM, an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI); ASCENIV, an IVIG product indicated for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B. 20 YEAR PERFORMANCE RESULTS |
ADMA Dividend History Detail ADMA Dividend News ADMA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |